Patients with non-alcoholic fatty liver disease (NAFLD) exhibited elevated levels of the NLRP3 inflammasome and caspase−1, an effector protein, as a consequence of an HFD [23]. Here, NLRP3 is linked to metabolic dysfunction-associated steatotic liver disease.